Saqib Islam
Amministratore Delegato presso SPRINGWORKS THERAPEUTICS, INC.
Patrimonio netto: 46 M $ in data 31/05/2024
Profilo
Saqib Islam is currently the Chief Executive Officer & Director at SpringWorks Therapeutics LLC and Springworks Therapeutics, Inc. He is also an Independent Non-Executive Director at Passage Bio, Inc. and an Independent Director at ARS Pharmaceuticals, Inc. In addition, Mr. Islam serves as the Chief Business Officer at ModernaTX, Inc. His former positions include Managing Director at Morgan Stanley and Credit Suisse Asset Management LLC, Independent Director at ARYA Sciences Acquisition Corp.
III, and Independent Director at Silverback Therapeutics, Inc. He was also the Executive VP, Chief Strategy & Portfolio Officer at Alexion Pharmaceuticals, Inc. Mr. Islam has an undergraduate degree from McGill University and a graduate degree from Columbia Law School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 03/06/2024 | 1 112 368 ( 1.50% ) | 46 M $ | 31/05/2024 | |
| 31/03/2024 | 15 239 ( 0.02% ) | 135 322 $ | 31/05/2024 | |
PASSAGE BIO, INC.
0.01% | 21/05/2024 | 5 000 ( 0.01% ) | 5 700 $ | 31/05/2024 |
Posizioni attive di Saqib Islam
| Società | Posizione | Inizio |
|---|---|---|
| PASSAGE BIO, INC. | Direttore/Membro del Consiglio | 29/03/2019 |
| SPRINGWORKS THERAPEUTICS, INC. | Amministratore Delegato | 01/08/2018 |
| ARS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 08/11/2022 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 09/05/2016 |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Amministratore Delegato | 01/08/2018 |
Precedenti posizioni note di Saqib Islam
| Società | Posizione | Fine |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/01/2022 |
| ARYA SCIENCES ACQUISITION III A | Direttore/Membro del Consiglio | 01/11/2021 |
| MODERNA, INC. | Corporate Officer/Principal | 01/08/2017 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2016 |
| ░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Saqib Islam
| McGill University | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| MORGAN STANLEY | Finance |
| PASSAGE BIO, INC. | Health Technology |
| SPRINGWORKS THERAPEUTICS, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| ARS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 8 |
|---|---|
Credit Suisse Asset Management LLC
 Credit Suisse Asset Management LLC Investment ManagersFinance Founded in 1999, Credit Suisse Asset Management LLC (CSAM) is a registered investment advisor headquartered in New York City. The firm is an indirect wholly-owned subsidiary of Credit Suisse Group AG (NYSE: CS), a publicly owned foreign bank holding company based in Switzerland. | Finance |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
| Merrill Lynch & Co., Inc. | Finance |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Health Technology |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
ARYA Sciences Acquisition Corp. III
 ARYA Sciences Acquisition Corp. III Financial ConglomeratesFinance ARYA Sciences Acquisition Corp III is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which it refers to as its initial business combination. It has not yet selected any business combination target. The company was founded by Joseph Edelman, Adam Stone, Michael Altman, and Konstantin Poukalov on March 27, 2020 and is headquartered in New York, NY. | Finance |
- Borsa valori
- Insiders
- Saqib Islam
